The RyR2:cMyBP-C association could also be relevant in DCM and HCM, cardiomyopathies often accompanied by an arrhythmogenic phenotype (Maron et al., 2014; Spezzacatene et al., 2015). Here, MYBPC3 is linked to cardiomyopathy.